Skip to main content
SpringerLink
Log in

Maternal Malnutrition, Glucocorticoids, and Fetal Programming: A Role for Placental 11β-Hydroxysteroid Dehydrogenase Type 2

  • Chapter
  • First Online:
Diet, Nutrition, and Fetal Programming

Part of the book series: Nutrition and Health ((NH))

  • 1673 Accesses

Abstract

Maternal malnutrition during pregnancy alters the growth and development of the fetus and associates with adverse adult health outcomes in the offspring. Frequently underlying these associations is overexposure of the fetus to glucocorticoids. Fetal exposure to glucocorticoids is primarily regulated by 11β-HSD2, which catalyzes the intracellular inactivation of glucocorticoids. This enzyme is abundantly expressed at the maternal-fetal interface of the placenta and within fetal tissues, thus limiting glucocorticoid passage to the fetus. This is critical as overexposure of the fetus to glucocorticoids perturbs placental and fetal growth and development. Maternal malnutrition (obesity, restriction of food intake, protein restriction) frequently results in a reduction of placental 11β-HSD2 as well as increases in maternal and fetal glucocorticoids. These have subsequent ramifications for not only fetal development but also placental development and function. This chapter highlights the critical role of placental and fetal glucocorticoid exposure in models of maternal malnutrition and developmental programming and focuses on the importance of placental 11β-HSD2 in determining these outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

11β-HSD2:

11-β hydroxysteroid dehydrogenase type 2

CBG:

Corticosteroid binding globulin

DOHAD:

Developmental programming of adult health and disease

GLUT:

Glucose transporter

HPA:

Hypothalamic-pituitary-adrenal

LPD:

Low-protein diet

PPAR:

Peroxisome proliferator-activated receptor

SAME:

Syndrome of apparent mineralocorticoid excess

VEGF:

Vascular endothelial growth factor

References

  1. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36(1):62–7.

    Article  CAS  PubMed  Google Scholar 

  2. Hales C, Barker D, Clark P, Cox L, Fall C, Osmond C, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303(6809):1019–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Langley-Evans SC. Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J Hypertens. 1997;15(5):537–44.

    Article  CAS  PubMed  Google Scholar 

  4. Cottrell EC, Holmes MC, Livingstone DE, Kenyon CJ, Seckl JR. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming. FASEB J. 2012;26(5):1866–74.

    Article  CAS  PubMed  Google Scholar 

  5. Lesage J, Blondeau B, Grino M, Breant B, Dupouy J. Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology. 2001;142(5):1692–702.

    Article  CAS  PubMed  Google Scholar 

  6. Martí O, Martí J, Armario A. Effects of chronic stress on food intake in rats: influence of stressor intensity and duration of daily exposure. Physiol Behav. 1994;55(4):747–53.

    Article  PubMed  Google Scholar 

  7. Baxter JD, Forsham PH. Tissue effects of glucocorticoids. Am J Med. 1972;53(5):573–89.

    Article  CAS  PubMed  Google Scholar 

  8. Young EA, Abelson J, Lightman SL. Cortisol pulsatility and its role in stress regulation and health. Front Neuroendocrinol. 2004;25(2):69–76.

    Article  CAS  PubMed  Google Scholar 

  9. Tsigos C, Chrousos GP. Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865–71.

    Article  PubMed  Google Scholar 

  10. Brien TG. Human corticosteroid binding globulin. Clin Endocrinol. 1981;14(2):193–212.

    Article  CAS  Google Scholar 

  11. Jung C, Ho JT, Torpy DJ, Rogers A, Doogue M, Lewis JG, et al. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab. 2011;96(5):1533–40.

    Article  CAS  PubMed  Google Scholar 

  12. Doe RP, Fernandez RL, Seal US. Measurement of corticosteroid-binding globulin in man. J Clin Endocrinol Metab. 1964;24(10):1029–39.

    Article  CAS  PubMed  Google Scholar 

  13. Seckl JR, Holmes MC. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal ‘programming’ of adult pathophysiology. Nat Clin Pract Endocrinol Metab. 2007;3(6):479–88.

    Article  CAS  PubMed  Google Scholar 

  14. Surbek D, Drack G, Irion O, Nelle M, Huang D, Hoesli I. Antenatal corticosteroids for fetal lung maturation in threatened preterm delivery: indications and administration. Arch Gynecol Obstet. 2012;286(2):277–81.

    Article  CAS  PubMed  Google Scholar 

  15. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 1995;9(13):1608–21.

    Article  CAS  PubMed  Google Scholar 

  16. Cole TJ, Blendy JA, Monaghan AP, Schmid W, Aguzzi A, Schütz G. Molecular genetic analysis of glucocorticoid signaling during mouse development. Steroids. 1995;60(1):93–6.

    Article  CAS  PubMed  Google Scholar 

  17. Diaz R, Brown RW, Seckl JR. Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions. J Neurosci. 1998;18(7):2570–80.

    CAS  PubMed  Google Scholar 

  18. Edwards CRW, Benediktsson R, Lindsay RS, Seckl JR. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? Lancet. 1993;341(8841):355–7.

    Article  CAS  PubMed  Google Scholar 

  19. Stewart PM, Rogerson FM, Mason J. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab. 1995;80(3):885–90.

    CAS  PubMed  Google Scholar 

  20. Burton PJ, Smith RE, Krozowski ZS, Waddell B. Zonal distribution of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 messenger ribonucleic acid expression in the rat placenta and decidua during late pregnancy. Biol Reprod. 1996;55(5):1023–8.

    Article  CAS  PubMed  Google Scholar 

  21. Brown R, Diaz R, Robson A, Kotelevtsev Y, Mullins J, Kaufman M, et al. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology. 1996;137(2):794–7.

    Article  CAS  PubMed  Google Scholar 

  22. Mark PJ, Waddell BJ. P-glycoprotein restricts access of cortisol and dexamethasone to the glucocorticoid receptor in placental BeWo cells. Endocrinology. 2006;147(11):5147–52.

    Article  CAS  PubMed  Google Scholar 

  23. Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, Gibb W. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta. 2006;27(6–7):602–9.

    Article  CAS  PubMed  Google Scholar 

  24. Condon J, Gosden C, Gardener D, Nickson P, Hewison M, Howie AJ, et al. Expression of type 2 11β-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J Clin Endocrinol Metab. 1998;83(12):4490–7.

    CAS  PubMed  Google Scholar 

  25. Brown R, Chapman KE, Kotelevtsev Y, Yau JLW, Linsday RS, Brett L, et al. Cloning and production of antisera to human placental 11 β-hydroxysteroid dehydrogenase type 2. Biochem J. 1996;313(3):1007–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Robson AC, Leckie CM, Seckl JR, Holmes MC. 11β-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Mol Brain Res. 1998;61(1–2):1–10.

    Article  CAS  PubMed  Google Scholar 

  27. Evans LC, Ivy JR, Wyrwoll C, McNairn JA, Menzies RI, Christensen TH, et al. Conditional deletion of Hsd11b2 in the brain causes salt appetite and hypertension. Circulation. 2016;133(14):1360–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Stewart PM, Gupta A, Sheppard MC, Whorwood CB, Howie AJ, Milford DV, et al. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene. Lancet. 1996;347(8994):88–91.

    Article  CAS  PubMed  Google Scholar 

  29. Benediktsson R, Calder AA, Edwards CR, Seckl JR. Placental 11β-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol. 1997;46(2):161–6.

    Article  CAS  Google Scholar 

  30. Reynolds RM. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis – 2012 Curt Richter award winner. Psychoneuroendocrinology. 2013;38(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  31. McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, et al. Reduced placental 11β-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab. 2001;86(10):4979–83.

    CAS  PubMed  Google Scholar 

  32. Rogerson FM, Kayes KM, White PC. Variation in placental type 2 11β-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol Cell Endocrinol. 1997;128(1–2):103–9.

    Article  CAS  PubMed  Google Scholar 

  33. Wyrwoll CS, Seckl JR, Holmes MC. Altered placental function of 11β-hydroxysteroid dehydrogenase 2 knockout mice. Endocrinology. 2009;150(3):1287–93.

    Article  CAS  PubMed  Google Scholar 

  34. Bloom SL, Sheffield JS, McIntire DD, Leveno KJ. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol. 2001;97(4):485–90.

    CAS  PubMed  Google Scholar 

  35. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet. 2005;365(9474):1856–62.

    Article  CAS  PubMed  Google Scholar 

  36. Doyle L, Ford G, Davis N, Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci. 2000;98(2):137–42.

    Article  CAS  PubMed  Google Scholar 

  37. Bolten MI, Wurmser H, Buske-Kirschbaum A, Papoušek M, Pirke K-M, Hellhammer D. Cortisol levels in pregnancy as a psychobiological predictor for birth weight. Arch Womens Ment Health. 2011;14(1):33–41.

    Article  PubMed  Google Scholar 

  38. Kitanaka S, Tanae A, Hibi I. Apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation. Clin Endocrinol (Oxf). 1996;44(3):353–9.

    Article  CAS  Google Scholar 

  39. Shams M, Kilby M, Somerset D, Howie A, Gupta A, Wood P, et al. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod. 1998;13(4):799–804.

    Article  CAS  PubMed  Google Scholar 

  40. Benediktsson R, Noble J, Calder A, Edwards C, Seckl J. 11β-hydroxysteroid dehydrogenase activity in intact dually perfused fresh human placenta predicts birth weight. J Endocrinol. 1995;144:161.

    Google Scholar 

  41. Strandberg TE, Järvenpää A-L, Vanhanen H, McKeigue PM. Birth outcome in relation to licorice consumption during pregnancy. Am J Epidemiol. 2001;153(11):1085–8.

    Article  CAS  PubMed  Google Scholar 

  42. Blanford AT, Pearson-Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol. 1977;127(3):264–7.

    Article  CAS  PubMed  Google Scholar 

  43. Vackova Z, Vagnerova K, Libra A, Miksik I, Pacha J, Staud F. Dexamethasone and betamethasone administration during pregnancy affects expression and function of 11β-hydroxysteroid dehydrogenase type 2 in the rat placenta. Reprod Toxicol. 2009;28(1):46–51.

    Article  CAS  PubMed  Google Scholar 

  44. Vaughan OR, Sferruzzi-Perri AN, Fowden AL. Maternal corticosterone regulates nutrient allocation to fetal growth in mice. J Physiol. 2012;590(21):5529–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Vaughan O, Fowden A. Preterm fetal cortisol overexposure alters placental glucose delivery nearer term. Placenta. 2014;35(9):A69–70.

    Article  Google Scholar 

  46. Lindsay R, Lindsay R, Waddell B, Seckl J. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 b-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia. 1996;39(11):1299–305.

    Article  CAS  PubMed  Google Scholar 

  47. Holmes MC, Abrahamsen CT, French KL, Paterson JM, Mullins JJ, Seckl JR. The mother or the fetus? 11β-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids. J Neurosci. 2006;26(14):3840–4.

    Article  CAS  PubMed  Google Scholar 

  48. Benediktsson R, Lindsay R, Noble J, Seckl J, Edwards C. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet. 1993;341(8841):339–41.

    Google Scholar 

  49. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Investig. 1998;101(10):2174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Ain R, Canham LN, Soares MJ. Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the Akt signaling pathway. J Endocrinol. 2005;185(2):253–63.

    Article  CAS  PubMed  Google Scholar 

  51. Hewitt DP, Mark PJ, Waddell BJ. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology. 2006;147(12):5568–74.

    Article  CAS  PubMed  Google Scholar 

  52. Cuffe JSM, Dickinson H, Simmons DG, Moritz KM. Sex specific changes in placental growth and MAPK following short term maternal dexamethasone exposure in the mouse. Placenta. 2011;32(12):981–9.

    Article  CAS  PubMed  Google Scholar 

  53. Lindsay R, Lindsay RM, Edwards CRW, Seckl JR. Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension. 1996;27(6):1200–4.

    Article  CAS  PubMed  Google Scholar 

  54. Wyrwoll CS, Mark PJ, Mori TA, Puddey IB, Waddell BJ. Prevention of programmed hyperleptinemia and hypertension by postnatal dietary ω-3 fatty acids. Endocrinology. 2006;147(1):599–606.

    Article  CAS  PubMed  Google Scholar 

  55. Sugden MC, Langdown ML, Munns MJ, Holness MJ. Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring. Eur J Endocrinol. 2001;145(4):529–39.

    Article  CAS  PubMed  Google Scholar 

  56. Newnham JP, Evans SF, Godfrey M, Huang W, Ikegami M, Jobe A. Maternal, but not fetal, administration of corticosteroids restricts fetal growth. J Maternal-Fetal Med. 1999;8(3):81–7.

    CAS  Google Scholar 

  57. Langdown ML, Sugden MC. Enhanced placental GLUT1 and GLUT3 expression in dexamethasone-induced fetal growth retardation. Mol Cell Endocrinol. 2001;185(1–2):109–17.

    Article  CAS  PubMed  Google Scholar 

  58. Vaughan OR, Sferruzzi-Perri AN, Coan PM, Fowden AL. Adaptations in placental phenotype depend on route and timing of maternal dexamethasone administration in mice. Biol Reprod. 2013;89(4):80. 1–12.

    Article  PubMed  Google Scholar 

  59. Hewitt DP, Mark PJ, Waddell BJ. Placental expression of peroxisome proliferator-activated receptors in rat pregnancy and the effect of increased glucocorticoid exposure. Biol Reprod. 2006;74(1):23–8.

    Article  CAS  PubMed  Google Scholar 

  60. Fowden AL, Forhead AJ, Sferruzzi-Perri AN, Burton GJ, Vaughan OR. Review: endocrine regulation of placental phenotype. Placenta. 2015;36(Supplement 1):S50–9.

    Article  CAS  PubMed  Google Scholar 

  61. Langley-Evans SC, Phillips GJ, Benediktsson R, Gardner DS, Edwards CRW, Jackson AA, et al. Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta. 1996;17(2–3):169–72.

    Article  CAS  PubMed  Google Scholar 

  62. Lesage J, Hahn D, Leonhardt M, Blondeau B, Breant B, Dupouy J. Maternal undernutrition during late gestation-induced intrauterine growth restriction in the rat is associated with impaired placental GLUT3 expression, but does not correlate with endogenous corticosterone levels. J Endocrinol. 2002;174(1):37–43.

    Article  CAS  PubMed  Google Scholar 

  63. Belkacemi L, Jelks A, Chen C-H, Ross MG, Desai M. Altered placental development in undernourished rats: role of maternal glucocorticoids. Reprod Biol Endocrinol. 2011;9(1):1–11.

    Article  Google Scholar 

  64. Grieger JA, Clifton VL. A review of the impact of dietary intakes in human pregnancy on infant birthweight. Forum Nutr. 2014;7(1):153–78.

    Google Scholar 

  65. Howie GJ, Sloboda DM, Kamal T, Vickers MH. Maternal nutritional history predicts obesity in adult offspring independent of postnatal diet. J Physiol. 2009;587(4):905–15.

    Article  CAS  PubMed  Google Scholar 

  66. Mark PJ, Sisala C, Connor K, Patel R, Lewis JL, Vickers MH, et al. A maternal high-fat diet in rat pregnancy reduces growth of the fetus and the placental junctional zone, but not placental labyrinth zone growth. J Dev Orig Health Dis. 2011;2(01):63–70.

    Article  CAS  Google Scholar 

  67. Nivoit P, Morens C, Van Assche F, Jansen E, Poston L, Remacle C, et al. Established diet-induced obesity in female rats leads to offspring hyperphagia, adiposity and insulin resistance. Diabetologia. 2009;52(6):1133–42.

    Article  CAS  PubMed  Google Scholar 

  68. Hayes EK, Lechowicz A, Petrik JJ, Storozhuk Y, Paez-Parent S, Dai Q, et al. Adverse fetal and neonatal outcomes associated with a life-long high fat diet: role of altered development of the placental vasculature. PLoS One. 2012;7(3):e33370.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Akyol A, Langley-Evans SC, McMullen S. Obesity induced by cafeteria feeding and pregnancy outcome in the rat. Br J Nutr. 2009;102(11):1601–10.

    Article  CAS  PubMed  Google Scholar 

  70. Sferruzzi-Perri AN, Vaughan OR, Haro M, Cooper WN, Musial B, Charalambous M, et al. An obesogenic diet during mouse pregnancy modifies maternal nutrient partitioning and the fetal growth trajectory. FASEB J. 2013;27(10):3928–37.

    Article  CAS  PubMed  Google Scholar 

  71. Roberts KA, Riley SC, Reynolds RM, Barr S, Evans M, Statham A, et al. Placental structure and inflammation in pregnancies associated with obesity. Placenta. 2011;32(3):247–54.

    Article  CAS  PubMed  Google Scholar 

  72. Huang L, Liu J, Feng L, Chen Y, Zhang J, Wang W. Maternal prepregnancy obesity is associated with higher risk of placental pathological lesions. Placenta. 2014;35(8):563–9.

    Article  PubMed  Google Scholar 

  73. Khan IY, Dekou V, Douglas G, Jensen R, Hanson MA, Poston L, et al. A high-fat diet during rat pregnancy or suckling induces cardiovascular dysfunction in adult offspring. Am J Physiol Regul Integr Comp Physiol. 2005;288(1):R127–33.

    Article  CAS  PubMed  Google Scholar 

  74. Samuelsson A-M, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen EHJM, et al. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension. 2008;51(2):383–92.

    Article  CAS  PubMed  Google Scholar 

  75. Stirrat LI, O’Reilly JR, Barr SM, Andrew R, Riley SC, Howie AF, et al. Decreased maternal hypothalamic-pituitary-adrenal axis activity in very severely obese pregnancy: associations with birthweight and gestation at delivery. Psychoneuroendocrinology. 2016;63:135–43.

    Article  CAS  PubMed  Google Scholar 

  76. Garofano A, Czernichow P, Bréant B. In utero undernutrition impairs rat beta-cell development. Diabetologia. 1997;40(10):1231–4.

    Article  CAS  PubMed  Google Scholar 

  77. Hietaniemi M, Malo E, Jokela M, Santaniemi M, Ukkola O, Kesäniemi YA. The effect of energy restriction during pregnancy on obesity-related peptide hormones in rat offspring. Peptides. 2009;30(4):705–9.

    Article  CAS  PubMed  Google Scholar 

  78. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab. 2000;279(1):E83–7.

    CAS  PubMed  Google Scholar 

  79. Zohdi V, Lim K, Pearson JT, Black MJ. Developmental programming of cardiovascular disease following intrauterine growth restriction: findings utilising a rat model of maternal protein restriction. Forum Nutr. 2014;7(1):119–52.

    Google Scholar 

  80. Rutland CS, Latunde-Dada AO, Thorpe A, Plant R, Langley-Evans S, Leach L. Effect of gestational nutrition on vascular integrity in the murine placenta. Placenta. 2007;28(7):734–42.

    Article  CAS  PubMed  Google Scholar 

  81. Doherty C, Lewis R, Sharkey A, Burton G. Placental composition and surface area but not vascularization are altered by maternal protein restriction in the rat. Placenta. 2003;24(1):34–8.

    Article  PubMed  Google Scholar 

  82. Jansson N, Pettersson J, Haafiz A, Ericsson A, Palmberg I, Tranberg M, et al. Down-regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet. J Physiol. 2006;576(3):935–46.

    CAS  PubMed  PubMed Central  Google Scholar 

  83. van Beek JP, Guan H, Julan L, Yang K. Glucocorticoids stimulate the expression of 11β-hydroxysteroid dehydrogenase type 2 in cultured human placental trophoblast cells. J Clin Endocrinol Metab. 2004;89(11):5614–21.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Human Sciences, The University of Western Australia, Crawley, WA, Australia

    Emily K. Chivers BSc & Caitlin S. Wyrwoll PhD

Authors
  1. Emily K. Chivers BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caitlin S. Wyrwoll PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caitlin S. Wyrwoll PhD .

Editor information

Editors and Affiliations

  1. Department of Nutrition, King's College, London, United Kingdom

    Rajkumar Rajendram

  2. Department of Nutrition, King's College, London, United Kingdom

    Victor R. Preedy

  3. Department of Biomedical Sciences, University of Westminster, London, United Kingdom

    Vinood B. Patel

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Chivers, E.K., Wyrwoll, C.S. (2017). Maternal Malnutrition, Glucocorticoids, and Fetal Programming: A Role for Placental 11β-Hydroxysteroid Dehydrogenase Type 2. In: Rajendram, R., Preedy, V., Patel, V. (eds) Diet, Nutrition, and Fetal Programming. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-60289-9_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-60289-9_39

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-60287-5

  • Online ISBN: 978-3-319-60289-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation